Gerongco, Renalyn P.

HRN: 28-29-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2025
CEFUROXIME 1.5GM (VIAL)
12/17/2025
12/17/2025
IV
1.5 G
PTOR
STAT CS
Waiting Final Action 
12/17/2025
CEFUROXIME 1.5GM (VIAL)
12/17/2025
12/19/2025
IV
1.5gm
Q8hr X 4doses
Sp PLTCS
Waiting Final Action 
12/17/2025
CEFUROXIME 500MG (TAB)
12/19/2025
12/25/2025
ORAL
500mg
BID X 7days
Sp PLTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: